
Angelini Ventures is the venture capital arm of Angelini Industries funded with a €300 million capital commitment to build and invest in companies that develop innovative ideas and solutions in biotechnology, digital health and life sciences. Angelini Ventures invests across Europe and North America with a focus on brain health and consumer segments such as women, children and the elderly. The company is headquartered in Rome with a global team spread across Europe, Asia and the US to provide global perspective and capabilities.